COVID-19 Outcomes in Myasthenia Gravis Patients: Analysis From Electronic Health Records in the United States

BACKGROUND: Myasthenia gravis (MG) is an autoimmune, neuromuscular condition and patients with MG are vulnerable due to immunosuppressant use and disease manifestations of dyspnea and dysphagia during the coronavirus disease 2019 (COVID-19) pandemic. METHODS: We conducted a retrospective cohort stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Youngran, Li, Xiaojin, Huang, Yan, Kim, Minseon, Shaibani, Aziz, Sheikh, Kazim, Zhang, Guo-Qiang, Nguyen, Thy Phuong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996116/
https://www.ncbi.nlm.nih.gov/pubmed/35418937
http://dx.doi.org/10.3389/fneur.2022.802559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996116/
https://www.ncbi.nlm.nih.gov/pubmed/35418937
http://dx.doi.org/10.3389/fneur.2022.802559

Ejemplares similares